<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, Oct. 15, 2020 (HealthDay News) — In a series of 101 newborns of mothers with perinatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there was no clinical evidence of vertical transmission, according to a study published online Oct. 12 in JAMA Pediatrics<\/i>.<\/p>\n
Dani Dumitriu, M.D., Ph.D., from Columbia University Irving Medical Center in New York City, and colleagues described the outcomes of neonates born to mothers with perinatal SARS-CoV-2 infection in a retrospective cohort review of medical records for 101 neonates born to 100 mothers positive for or with suspected SARS-CoV-2. Eighty-two of the newborns were admitted to well-baby nurseries and roomed-in with their mothers, who were required to wear masks. After appropriate hygiene, direct breastfeeding was encouraged.<\/p>\n
A total of 141 SARS-CoV-2 tests were obtained from 101 newborns at 0 to 25 days of life. The researchers found that two newborns had indeterminate test results, indicating low viral load; one remained well on follow-up and did not undergo retesting, while the other was negative on retesting. Compared with newborns of mothers with asymptomatic\/mild COVID-19, those with maternal severe\/critical COVID-19 had newborns born about one week earlier (median gestational age, 37.9 versus 39.1 weeks), and these newborns were at increased risk for requiring phototherapy (30 versus 7 percent).<\/p>\n
“We think it’s particularly important that mothers with COVID-19 have the opportunity to directly breastfeed their newborns,” one coauthor said in a statement. “Breast milk is known to protect newborns against numerous pathogens, and it may help protect newborns against infection with SARS-CoV-2.”<\/p>\n
Several authors disclosed ties to biomedical industries.<\/p>\n
Abstract\/Full Text<\/a><\/p>\n